Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2012

01-05-2012 | Review

Oxidative stress in Phenylketonuria: future directions

Authors: Júlio César Rocha, Maria João Martins

Published in: Journal of Inherited Metabolic Disease | Issue 3/2012

Login to get access

Abstract

Phenylketonuria represents the most prevalent inborn error of amino acid metabolism. In early diagnosed patients adequate and continued dietary treatment results in a good neurologic outcome. Natural protein and phenylalanine-restricted diet, even if rich in fruits and vegetables, represents a serious risk for nutritional deficiencies, albeit universally accepted. In the last few years, a growing number of reports have been describing oxidative stress as a concern in phenylketonuric patients. The diet itself includes good sources of dietary antioxidants (phytochemicals, some vitamins and minerals) but also a risk factor for some deficiencies (selenium, zinc, ubiquinone-10 and L-carnitine). Additionally, the extreme stringency of the diet may impose a reduced synthesis of endogenous antioxidants (like ubiquinone-10 and glutathione). Furthermore, increased phenylalanine levels, and its metabolites, may enhance the endogenous synthesis of reactive species and free radicals and/or interfere with the endogenous synthesis of enzymatic antioxidants (like glutathione peroxidase). Therefore, oxidative stress will probably increase, mainly in late diagnosed patients or in those with bad metabolic control. Considering the known association between oxidative stress, obesity and cardiovascular disease, it seems advisable to look further to the impact of oxidative stress on body macromolecules and structures (like lipoprotein oxidation), especially in phenylketonuric patients with late diagnosis or bad metabolic control, in order to prevent future increased risks. Recommendations for PKU patient’s clinical follow-up improvement and educational goals are included.
Literature
go back to reference Artuch R, Vilaseca MA, Moreno J, Lambruschini N, Cambra FJ, Campistol J (1999) Decreased serum ubiquinone-10 concentrations in phenylketonuria. Am J Clin Nutr 70:892–895PubMed Artuch R, Vilaseca MA, Moreno J, Lambruschini N, Cambra FJ, Campistol J (1999) Decreased serum ubiquinone-10 concentrations in phenylketonuria. Am J Clin Nutr 70:892–895PubMed
go back to reference Artuch R, Colome C, Vilaseca MA et al. (2001) Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria. J Inherit Metab Dis 24:359–366PubMedCrossRef Artuch R, Colome C, Vilaseca MA et al. (2001) Plasma phenylalanine is associated with decreased serum ubiquinone-10 concentrations in phenylketonuria. J Inherit Metab Dis 24:359–366PubMedCrossRef
go back to reference Artuch R, Colome C, Sierra C et al. (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198–203PubMedCrossRef Artuch R, Colome C, Sierra C et al. (2004) A longitudinal study of antioxidant status in phenylketonuric patients. Clin Biochem 37:198–203PubMedCrossRef
go back to reference Aviram M, Kaplan M, Rosenblat M, Fuhrman B (2005) Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb Exp Pharmacol: 263–300 Aviram M, Kaplan M, Rosenblat M, Fuhrman B (2005) Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb Exp Pharmacol: 263–300
go back to reference Bao B, Prasad AS, Beck FW et al. (2010) Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 91:1634–1641PubMedCrossRef Bao B, Prasad AS, Beck FW et al. (2010) Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 91:1634–1641PubMedCrossRef
go back to reference Barretto JR, Silva LR, Leite ME et al. (2008) Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil. Nutr Res 28:208–211PubMedCrossRef Barretto JR, Silva LR, Leite ME et al. (2008) Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil. Nutr Res 28:208–211PubMedCrossRef
go back to reference Bergamini CM, Gambetti S, Dondi A, Cervellati C (2004) Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 10:1611–1626PubMedCrossRef Bergamini CM, Gambetti S, Dondi A, Cervellati C (2004) Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 10:1611–1626PubMedCrossRef
go back to reference Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M (2009) Metabolic syndrome and periodontitis: is oxidative stress a common link? J Dent Res 88:503–518PubMedCrossRef Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M (2009) Metabolic syndrome and periodontitis: is oxidative stress a common link? J Dent Res 88:503–518PubMedCrossRef
go back to reference Butler JA, Beilstein MA, Whanger PD (1989) Influence of dietary methionine on the metabolism of selenomethionine in rats. J Nutr 119:1001–1009PubMed Butler JA, Beilstein MA, Whanger PD (1989) Influence of dietary methionine on the metabolism of selenomethionine in rats. J Nutr 119:1001–1009PubMed
go back to reference Campistol J, Perez-Duenas B, Montero R, Artuch R, Conill J, Vilaseca MA (2006) Coenzyme Q10 deficiency seems to be implicated in the pathophysiology of tremor in patients with phenylketonuria. J Inherit Metab Dis 29(suppl 1):96 Campistol J, Perez-Duenas B, Montero R, Artuch R, Conill J, Vilaseca MA (2006) Coenzyme Q10 deficiency seems to be implicated in the pathophysiology of tremor in patients with phenylketonuria. J Inherit Metab Dis 29(suppl 1):96
go back to reference Camps J, Marsillach J, Joven J (2009) The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 46:83–106PubMedCrossRef Camps J, Marsillach J, Joven J (2009) The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 46:83–106PubMedCrossRef
go back to reference Castillo M, Zafra MF, Garcia-Peregrin E (1988) Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia. Neurochem Res 13:551–555PubMedCrossRef Castillo M, Zafra MF, Garcia-Peregrin E (1988) Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia. Neurochem Res 13:551–555PubMedCrossRef
go back to reference Castillo M, Iglesias J, Zafra MF, Garcia-Peregrin E (1991a) Inhibition of chick brain cholesterogenic enzymes by phenyl and phenolic derivatives of phenylalanine. Neurochem Int 18:171–174PubMedCrossRef Castillo M, Iglesias J, Zafra MF, Garcia-Peregrin E (1991a) Inhibition of chick brain cholesterogenic enzymes by phenyl and phenolic derivatives of phenylalanine. Neurochem Int 18:171–174PubMedCrossRef
go back to reference Castillo M, Martinez-Cayuela M, Zafra MF, Garcia-Peregrin E (1991b) Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis. Mol Cell Biochem 105:21–25PubMedCrossRef Castillo M, Martinez-Cayuela M, Zafra MF, Garcia-Peregrin E (1991b) Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis. Mol Cell Biochem 105:21–25PubMedCrossRef
go back to reference Colomé C, Artuch R, Lambruschini N, Cambra FJ, Campistol J, Vilaseca M (2001) Is there a relationship between plasma phenylalanine and cholesterol in phenylketonuric patients under dietary treatment? Clin Biochem 34:373–376PubMedCrossRef Colomé C, Artuch R, Lambruschini N, Cambra FJ, Campistol J, Vilaseca M (2001) Is there a relationship between plasma phenylalanine and cholesterol in phenylketonuric patients under dietary treatment? Clin Biochem 34:373–376PubMedCrossRef
go back to reference Colomé C, Artuch R, Vilaseca MA et al. (2002) Ubiquinone-10 content in lymphocytes of phenylketonuric patients. Clin Biochem 35:81–84PubMedCrossRef Colomé C, Artuch R, Vilaseca MA et al. (2002) Ubiquinone-10 content in lymphocytes of phenylketonuric patients. Clin Biochem 35:81–84PubMedCrossRef
go back to reference Colomé C, Artuch R, Vilaseca MA et al. (2003) Lipophilic antioxidants in patients with phenylketonuria. Am J Clin Nutr 77:185–188PubMed Colomé C, Artuch R, Vilaseca MA et al. (2003) Lipophilic antioxidants in patients with phenylketonuria. Am J Clin Nutr 77:185–188PubMed
go back to reference Craig WJ, Mangels AR (2009) Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc 109:1266–1282PubMedCrossRef Craig WJ, Mangels AR (2009) Position of the American Dietetic Association: vegetarian diets. J Am Diet Assoc 109:1266–1282PubMedCrossRef
go back to reference Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001–1043PubMedCrossRef Crozier A, Jaganath IB, Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26:1001–1043PubMedCrossRef
go back to reference de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 99(Suppl 1):S86–S89PubMedCrossRef de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 99(Suppl 1):S86–S89PubMedCrossRef
go back to reference DiSilvestro RA, Blostein-Fujii A (1997) Moderate zinc deficiency in rats enhances lipoprotein oxidation in vitro. Free Radic Biol Med 22:739–742PubMedCrossRef DiSilvestro RA, Blostein-Fujii A (1997) Moderate zinc deficiency in rats enhances lipoprotein oxidation in vitro. Free Radic Biol Med 22:739–742PubMedCrossRef
go back to reference Efrat M, Aviram M (2010) Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids. Adv Exp Med Biol 660:153–166PubMedCrossRef Efrat M, Aviram M (2010) Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids. Adv Exp Med Biol 660:153–166PubMedCrossRef
go back to reference Enns GM, Koch R, Brumm V, Blakely E, Suter R, Jurecki E (2010) Suboptimal outcomes in patients with PKU treated early with diet al.one: revisiting the evidence. Mol Genet Metab 101:99–109PubMedCrossRef Enns GM, Koch R, Brumm V, Blakely E, Suter R, Jurecki E (2010) Suboptimal outcomes in patients with PKU treated early with diet al.one: revisiting the evidence. Mol Genet Metab 101:99–109PubMedCrossRef
go back to reference Farbstein D, Kozak-Blickstein A, Levy AP (2010) Antioxidant vitamins and their use in preventing cardiovascular disease. Molecules 15:8098–8110PubMedCrossRef Farbstein D, Kozak-Blickstein A, Levy AP (2010) Antioxidant vitamins and their use in preventing cardiovascular disease. Molecules 15:8098–8110PubMedCrossRef
go back to reference Feillet F, Agostoni C (2010) Nutritional issues in treating phenylketonuria. J Inherit Metab Dis 33:659–664PubMedCrossRef Feillet F, Agostoni C (2010) Nutritional issues in treating phenylketonuria. J Inherit Metab Dis 33:659–664PubMedCrossRef
go back to reference Fernandes CG, Leipnitz G, Seminotti B et al. (2010) Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats. Cell Mol Neurobiol 30:317–326PubMedCrossRef Fernandes CG, Leipnitz G, Seminotti B et al. (2010) Experimental evidence that phenylalanine provokes oxidative stress in hippocampus and cerebral cortex of developing rats. Cell Mol Neurobiol 30:317–326PubMedCrossRef
go back to reference Fisberg RM, Da Silva-Femandes ME, Fisberg M, Schmidt BJ (1999) Plasma zinc, copper, and erythrocyte superoxide dismutase in children with phenylketonuria. Nutrition 15:449–452PubMedCrossRef Fisberg RM, Da Silva-Femandes ME, Fisberg M, Schmidt BJ (1999) Plasma zinc, copper, and erythrocyte superoxide dismutase in children with phenylketonuria. Nutrition 15:449–452PubMedCrossRef
go back to reference Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP (2008) Multiple actions of high-density lipoprotein. Curr Opin Cardiol 23:370–378PubMedCrossRef Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP (2008) Multiple actions of high-density lipoprotein. Curr Opin Cardiol 23:370–378PubMedCrossRef
go back to reference Fritz IB, Arrigoni-Martelli E (1993) Sites of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes. Trends Pharmacol Sci 14:355–360PubMedCrossRef Fritz IB, Arrigoni-Martelli E (1993) Sites of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes. Trends Pharmacol Sci 14:355–360PubMedCrossRef
go back to reference Furukawa S, Fujita T, Shimabukuro M et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752–1761PubMed Furukawa S, Fujita T, Shimabukuro M et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752–1761PubMed
go back to reference Garin MC, Kalix B, Morabia A, James RW (2005) Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. J Clin Endocrinol Metab 90:2264–2269PubMedCrossRef Garin MC, Kalix B, Morabia A, James RW (2005) Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome. J Clin Endocrinol Metab 90:2264–2269PubMedCrossRef
go back to reference Getz GS, Reardon CA (2004) Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol 15:261–267PubMedCrossRef Getz GS, Reardon CA (2004) Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol 15:261–267PubMedCrossRef
go back to reference Gropper SS, Gropper DM, Acosta PB (1993) Plasma amino acid response to ingestion of L-amino acids and whole protein. J Pediatr Gastroenterol Nutr 16:143–150PubMedCrossRef Gropper SS, Gropper DM, Acosta PB (1993) Plasma amino acid response to ingestion of L-amino acids and whole protein. J Pediatr Gastroenterol Nutr 16:143–150PubMedCrossRef
go back to reference Güllçin I (2006) Antioxidant and antiradical activities of L-carnitine. Life Sci 78:803–811CrossRef Güllçin I (2006) Antioxidant and antiradical activities of L-carnitine. Life Sci 78:803–811CrossRef
go back to reference Haldar S, Rowland IR, Barnett YA et al. (2007) Influence of habitual diet on antioxidant status: a study in a population of vegetarians and omnivores. Eur J Clin Nutr 61:1011–1022PubMedCrossRef Haldar S, Rowland IR, Barnett YA et al. (2007) Influence of habitual diet on antioxidant status: a study in a population of vegetarians and omnivores. Eur J Clin Nutr 61:1011–1022PubMedCrossRef
go back to reference Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine. Clarendon Press, Oxford Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine. Clarendon Press, Oxford
go back to reference Hansel B, Kontush A, Bonnefont-Rousselot D, Bruckert E, Chapman MJ (2006) Alterations in lipoprotein defense against oxidative stress in metabolic syndrome. Curr Atheroscler Rep 8:501–509PubMedCrossRef Hansel B, Kontush A, Bonnefont-Rousselot D, Bruckert E, Chapman MJ (2006) Alterations in lipoprotein defense against oxidative stress in metabolic syndrome. Curr Atheroscler Rep 8:501–509PubMedCrossRef
go back to reference Hargreaves IP (2007) Coenzyme Q10 in phenylketonuria and mevalonic aciduria. Mitochondrion 7(Suppl):S175–S180PubMedCrossRef Hargreaves IP (2007) Coenzyme Q10 in phenylketonuria and mevalonic aciduria. Mitochondrion 7(Suppl):S175–S180PubMedCrossRef
go back to reference Hargreaves IP, Heales SJ, Briddon A, Land JM, Lee PJ (2002) Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patients. J Inherit Metab Dis 25:673–679PubMedCrossRef Hargreaves IP, Heales SJ, Briddon A, Land JM, Lee PJ (2002) Blood mononuclear cell coenzyme Q10 concentration and mitochondrial respiratory chain succinate cytochrome-c reductase activity in phenylketonuric patients. J Inherit Metab Dis 25:673–679PubMedCrossRef
go back to reference Herbert V (1994) The antioxidant supplement myth. Am J Clin Nutr 60:157–158PubMed Herbert V (1994) The antioxidant supplement myth. Am J Clin Nutr 60:157–158PubMed
go back to reference Holvoet P, De Keyzer D, Jacobs DR (2008a) Oxidized LDL and the metabolic syndrome. Future Lipidol 3:637–649PubMedCrossRef Holvoet P, De Keyzer D, Jacobs DR (2008a) Oxidized LDL and the metabolic syndrome. Future Lipidol 3:637–649PubMedCrossRef
go back to reference Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr (2008b) Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299:2287–2293PubMedCrossRef Holvoet P, Lee DH, Steffes M, Gross M, Jacobs DR Jr (2008b) Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299:2287–2293PubMedCrossRef
go back to reference Hopps E, Noto D, Caimi G, Averna MR (2010) A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis 20:72–77PubMedCrossRef Hopps E, Noto D, Caimi G, Averna MR (2010) A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis 20:72–77PubMedCrossRef
go back to reference Jochum F, Terwolbeck K, Meinhold H, Behne D, Menzel H, Lombeck I (1997) Effects of a low selenium state in patients with phenylketonuria. Acta Paediatr 86:775–777PubMedCrossRef Jochum F, Terwolbeck K, Meinhold H, Behne D, Menzel H, Lombeck I (1997) Effects of a low selenium state in patients with phenylketonuria. Acta Paediatr 86:775–777PubMedCrossRef
go back to reference Key TJ, Appleby PN, Rosell MS (2006) Health effects of vegetarian and vegan diets. Proc Nutr Soc 65:35–41PubMedCrossRef Key TJ, Appleby PN, Rosell MS (2006) Health effects of vegetarian and vegan diets. Proc Nutr Soc 65:35–41PubMedCrossRef
go back to reference Kyprianou N, Murphy E, Lee P, Hargreaves I (2009) Assessment of mitochondrial respiratory chain function in hyperphenylalaninaemia. J Inherit Metab Dis 32:289–296PubMedCrossRef Kyprianou N, Murphy E, Lee P, Hargreaves I (2009) Assessment of mitochondrial respiratory chain function in hyperphenylalaninaemia. J Inherit Metab Dis 32:289–296PubMedCrossRef
go back to reference Lindsay DG, Astley SB (2002) European research on the functional effects of dietary antioxidants - EUROFEDA. Mol Aspects Med 23:1–38PubMedCrossRef Lindsay DG, Astley SB (2002) European research on the functional effects of dietary antioxidants - EUROFEDA. Mol Aspects Med 23:1–38PubMedCrossRef
go back to reference Lombeck I, Menzel H, Steiner G, Kasperek K (1982) Selenium supplementation: plasma glutathione peroxidase an indicator of selenium intake. Klin Padiatr 194:303–305PubMedCrossRef Lombeck I, Menzel H, Steiner G, Kasperek K (1982) Selenium supplementation: plasma glutathione peroxidase an indicator of selenium intake. Klin Padiatr 194:303–305PubMedCrossRef
go back to reference Lonnerdal B (1997) Effects of milk and milk components on calcium, magnesium, and trace element absorption during infancy. Physiol Rev 77:643–669PubMed Lonnerdal B (1997) Effects of milk and milk components on calcium, magnesium, and trace element absorption during infancy. Physiol Rev 77:643–669PubMed
go back to reference MacDonald A, Rylance G, Davies P, Asplin D, Hall SK, Booth IW (2003) Free use of fruits and vegetables in phenylketonuria. J Inherit Metab Dis 26:327–338PubMedCrossRef MacDonald A, Rylance G, Davies P, Asplin D, Hall SK, Booth IW (2003) Free use of fruits and vegetables in phenylketonuria. J Inherit Metab Dis 26:327–338PubMedCrossRef
go back to reference Macdonald A, Rocha JC, van Rijn M, Feillet F (2011) Nutrition in phenylketonuria. Mol Genet Metab Macdonald A, Rocha JC, van Rijn M, Feillet F (2011) Nutrition in phenylketonuria. Mol Genet Metab
go back to reference Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1–15PubMedCrossRef Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192:1–15PubMedCrossRef
go back to reference Moyle JJ, Fox AM, Arthur M, Bynevelt M, Burnett JR (2007) Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU. Neuropsychol Rev 17:91–101PubMedCrossRef Moyle JJ, Fox AM, Arthur M, Bynevelt M, Burnett JR (2007) Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU. Neuropsychol Rev 17:91–101PubMedCrossRef
go back to reference Ng CJ, Wadleigh DJ, Gangopadhyay A et al. (2001) Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 276:44444–44449PubMedCrossRef Ng CJ, Wadleigh DJ, Gangopadhyay A et al. (2001) Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 276:44444–44449PubMedCrossRef
go back to reference Pardridge WM (1977) Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem 28:103–108PubMedCrossRef Pardridge WM (1977) Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier. J Neurochem 28:103–108PubMedCrossRef
go back to reference Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr 12:646–652CrossRef Prasad AS (2009) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr 12:646–652CrossRef
go back to reference Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH (2004) Antioxidant effect of zinc in humans. Free Radic Biol Med 37:1182–1190PubMedCrossRef Prasad AS, Bao B, Beck FW, Kucuk O, Sarkar FH (2004) Antioxidant effect of zinc in humans. Free Radic Biol Med 37:1182–1190PubMedCrossRef
go back to reference Précourt LP, Amre D, Denis MC et al. (2010) The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 214:20–36PubMedCrossRef Précourt LP, Amre D, Denis MC et al. (2010) The three-gene paraoxonase family: physiologic roles, actions and regulation. Atherosclerosis 214:20–36PubMedCrossRef
go back to reference Ribas GS, Sitta A, Wajner M, Vargas CR (2011) Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol 31:653–662PubMedCrossRef Ribas GS, Sitta A, Wajner M, Vargas CR (2011) Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol 31:653–662PubMedCrossRef
go back to reference Rizzo M, Kotur-Stevuljevic J, Berneis K et al. (2009) Atherogenic dyslipidemia and oxidative stress: a new look. Transl Res 153:217–223PubMedCrossRef Rizzo M, Kotur-Stevuljevic J, Berneis K et al. (2009) Atherogenic dyslipidemia and oxidative stress: a new look. Transl Res 153:217–223PubMedCrossRef
go back to reference Robinson M, White FJ, Cleary MA, Wraith E, Lam WK, Walter JH (2000) Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. J Pediatr 136:545–547PubMedCrossRef Robinson M, White FJ, Cleary MA, Wraith E, Lam WK, Walter JH (2000) Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. J Pediatr 136:545–547PubMedCrossRef
go back to reference Rocha JC, Martel F (2009) Large neutral amino acids supplementation in phenylketonuric patients. J Inherit Metab Dis 32:472–480PubMedCrossRef Rocha JC, Martel F (2009) Large neutral amino acids supplementation in phenylketonuric patients. J Inherit Metab Dis 32:472–480PubMedCrossRef
go back to reference Sanayama Y, Nagasaka H, Takayanagi M, et al. (2011) Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol Genet Metab Sanayama Y, Nagasaka H, Takayanagi M, et al. (2011) Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria. Mol Genet Metab
go back to reference Schulpis KH, Nounopoulos C, Scarpalezou A, Bouloukos A, Missiou-Tsagarakis S (1990) Serum carnitine level in phenylketonuric children under dietary control in Greece. Acta Paediatr Scand 79:930–934PubMedCrossRef Schulpis KH, Nounopoulos C, Scarpalezou A, Bouloukos A, Missiou-Tsagarakis S (1990) Serum carnitine level in phenylketonuric children under dietary control in Greece. Acta Paediatr Scand 79:930–934PubMedCrossRef
go back to reference Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P (2003) Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 57:383–387PubMedCrossRef Schulpis KH, Tsakiris S, Karikas GA, Moukas M, Behrakis P (2003) Effect of diet on plasma total antioxidant status in phenylketonuric patients. Eur J Clin Nutr 57:383–387PubMedCrossRef
go back to reference Schulpis KH, Karakonstantakis T, Bartzeliotou A, Karikas GA, Papassotiriou I (2004) The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. Clin Nutr 23:401–407PubMedCrossRef Schulpis KH, Karakonstantakis T, Bartzeliotou A, Karikas GA, Papassotiriou I (2004) The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet. Clin Nutr 23:401–407PubMedCrossRef
go back to reference Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I (2005) Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem 38:239–242PubMedCrossRef Schulpis KH, Tsakiris S, Traeger-Synodinos J, Papassotiriou I (2005) Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria. Clin Biochem 38:239–242PubMedCrossRef
go back to reference Schulpis KH, Bartzeliotou A, Tsakiris S, Gounaris A, Papassotiriou I (2007) Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet. Eur J Clin Nutr 61:803–808PubMedCrossRef Schulpis KH, Bartzeliotou A, Tsakiris S, Gounaris A, Papassotiriou I (2007) Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet. Eur J Clin Nutr 61:803–808PubMedCrossRef
go back to reference Schulpis KH, Papastamataki M, Stamou H, Papassotiriou I, Margeli A (2010) The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children. Acta Paediatr 99:1565–1570PubMedCrossRef Schulpis KH, Papastamataki M, Stamou H, Papassotiriou I, Margeli A (2010) The effect of diet on total antioxidant status, ceruloplasmin, transferrin and ferritin serum levels in phenylketonuric children. Acta Paediatr 99:1565–1570PubMedCrossRef
go back to reference Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Sly WS (eds) The metabolic & molecular bases of inherited disease, vol 2, 8th edn. McGraw-Hill, New York, pp 1667–1724 Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Sly WS (eds) The metabolic & molecular bases of inherited disease, vol 2, 8th edn. McGraw-Hill, New York, pp 1667–1724
go back to reference Seifried HE, Anderson DE, Fisher EI, Milner JA (2007) A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 18:567–579PubMedCrossRef Seifried HE, Anderson DE, Fisher EI, Milner JA (2007) A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 18:567–579PubMedCrossRef
go back to reference Sierra C, Vilaseca MA, Moyano D et al. (1998) Antioxidant status in hyperphenylalaninemia. Clin Chim Acta 276:1–9PubMedCrossRef Sierra C, Vilaseca MA, Moyano D et al. (1998) Antioxidant status in hyperphenylalaninemia. Clin Chim Acta 276:1–9PubMedCrossRef
go back to reference Sirtori LR, Dutra-Filho CS, Fitarelli D et al. (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68–73PubMed Sirtori LR, Dutra-Filho CS, Fitarelli D et al. (2005) Oxidative stress in patients with phenylketonuria. Biochim Biophys Acta 1740:68–73PubMed
go back to reference Sitta A, Barschak AG, Deon M et al. (2006) Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 21:287–296PubMedCrossRef Sitta A, Barschak AG, Deon M et al. (2006) Investigation of oxidative stress parameters in treated phenylketonuric patients. Metab Brain Dis 21:287–296PubMedCrossRef
go back to reference Sitta A, Barschak AG, Deon M et al. (2009a) Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients. Int J Dev Neurosci 27:243–247PubMedCrossRef Sitta A, Barschak AG, Deon M et al. (2009a) Effect of short- and long-term exposition to high phenylalanine blood levels on oxidative damage in phenylketonuric patients. Int J Dev Neurosci 27:243–247PubMedCrossRef
go back to reference Sitta A, Barschak AG, Deon M et al. (2009b) L-carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol Neurobiol 29:211–218PubMedCrossRef Sitta A, Barschak AG, Deon M et al. (2009b) L-carnitine blood levels and oxidative stress in treated phenylketonuric patients. Cell Mol Neurobiol 29:211–218PubMedCrossRef
go back to reference Sitta A, Manfredini V, Biasi L et al. (2009c) Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Mutat Res 679:13–16PubMed Sitta A, Manfredini V, Biasi L et al. (2009c) Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Mutat Res 679:13–16PubMed
go back to reference Sitta A, Vanzin CS, Biancini GB et al. (2011) Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell Mol Neurobiol 31:429–436PubMedCrossRef Sitta A, Vanzin CS, Biancini GB et al. (2011) Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell Mol Neurobiol 31:429–436PubMedCrossRef
go back to reference Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40PubMedCrossRef Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40PubMedCrossRef
go back to reference Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84PubMedCrossRef Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44–84PubMedCrossRef
go back to reference van Bakel MM, Printzen G, Wermuth B, Wiesmann UN (2000) Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 72:976–981PubMed van Bakel MM, Printzen G, Wermuth B, Wiesmann UN (2000) Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 72:976–981PubMed
go back to reference van Spronsen FJ, Enns GM (2010) Future treatment strategies in phenylketonuria. Mol Genet Metab 99(Suppl 1):S90–S95PubMedCrossRef van Spronsen FJ, Enns GM (2010) Future treatment strategies in phenylketonuria. Mol Genet Metab 99(Suppl 1):S90–S95PubMedCrossRef
go back to reference van Spronsen FJ, Hoeksma M, Reijngoud DJ (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46–51PubMedCrossRef van Spronsen FJ, Hoeksma M, Reijngoud DJ (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46–51PubMedCrossRef
go back to reference Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427–448PubMedCrossRef Wajner M, Latini A, Wyse AT, Dutra-Filho CS (2004) The role of oxidative damage in the neuropathology of organic acidurias: insights from animal studies. J Inherit Metab Dis 27:427–448PubMedCrossRef
go back to reference Walter JH, White FJ (2004) Blood phenylalanine control in adolescents with phenylketonuria. Int J Adolesc Med Health 16:41–45PubMed Walter JH, White FJ (2004) Blood phenylalanine control in adolescents with phenylketonuria. Int J Adolesc Med Health 16:41–45PubMed
go back to reference Walter JH, White FJ, Hall SK et al. (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef Walter JH, White FJ, Hall SK et al. (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef
go back to reference Weber C, Bysted A, Hllmer G (1997a) The coenzyme Q10 content of the average Danish diet. Int J Vitam Nutr Res 67:123–129PubMed Weber C, Bysted A, Hllmer G (1997a) The coenzyme Q10 content of the average Danish diet. Int J Vitam Nutr Res 67:123–129PubMed
go back to reference Weber C, Bysted A, Holmer G (1997b) Coenzyme Q10 in the diet–daily intake and relative bioavailability. Mol Aspects Med 18(Suppl):S251–S254PubMedCrossRef Weber C, Bysted A, Holmer G (1997b) Coenzyme Q10 in the diet–daily intake and relative bioavailability. Mol Aspects Med 18(Suppl):S251–S254PubMedCrossRef
go back to reference Wilke BC, Vidailhet M, Favier A et al. (1992) Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation. Clin Chim Acta 207:137–142PubMedCrossRef Wilke BC, Vidailhet M, Favier A et al. (1992) Selenium, glutathione peroxidase (GSH-Px) and lipid peroxidation products before and after selenium supplementation. Clin Chim Acta 207:137–142PubMedCrossRef
go back to reference Willett WC, MacMahon B (1984b) Diet and cancer–an overview (second of two parts). N Engl J Med 310:697–703PubMedCrossRef Willett WC, MacMahon B (1984b) Diet and cancer–an overview (second of two parts). N Engl J Med 310:697–703PubMedCrossRef
go back to reference Witztum JL, Steinberg D (2001) The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovas Med 11:93–102CrossRef Witztum JL, Steinberg D (2001) The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovas Med 11:93–102CrossRef
Metadata
Title
Oxidative stress in Phenylketonuria: future directions
Authors
Júlio César Rocha
Maria João Martins
Publication date
01-05-2012
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2012
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9417-2

Other articles of this Issue 3/2012

Journal of Inherited Metabolic Disease 3/2012 Go to the issue